Biopharmaceuticals
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
Aim & Scope
This section is dedicated to research on the therapeutic, diagnostic, prognostic and immunoprophylactic developments of important biological macromolecules built from amino acids, sugars, nucleic acids, comprising small basic units of which they are composed, and mimetics produced by chemical synthesis. Contributions focusing on biopharmaceutical applications of more complex entities, such as phages, viruses, exosomes and stem cells, among others, are also welcome. Also reports on structure and molecular interactions determinant for biopharmaceuticals bioactivity or pharmaceutical applications, e.g. by computational and NMR studies are also accepted.
Keywords
- Peptides
- Proteins
- RNARNA
- DNA
- Nucleic Acids
- Aptamers
- Carbohydrates
- Glycans
- Polysaccharides
- Macromolecules
- Chemical Synthesis
- Ribonucleoproteins
- Antibodies
- Phages
- Viruses
- Therapeutic Tools
- Peptidomimetics
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Glycomics in Drug Discovery (Deadline: 26 June 2022)
- Biologically Active Peptides Derived from Peptide Hormones as Potential Drugs (Deadline: 30 June 2022)
- New Applications and Developments in Synthetic Peptide Chemistry (Deadline: 15 July 2022)
- Non-Natural Amino Acids in Drug Design (Deadline: 29 July 2022)
- Recent Developments of Coagulation Factor Products for Hemophilia Treatment (Deadline: 30 July 2022)
- Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps (Deadline: 15 September 2022)
- siRNA Therapeutics: From Bench Lab to Clinics (Deadline: 15 September 2022)
- Co-and Post-translational Modifications of Therapeutic Proteins (Deadline: 31 October 2022)
- Recent Advances in Drug Discovery Based on β-Glucans (Deadline: 28 February 2023)
- Adjuvants for Human Vaccines (Deadline: 30 April 2023)